With advancing age, a natural decline in cell-mediated immunity to varicella zoster virus (VZV) results in virus reactivation (herpes zoster) often complicated by VZV vasculopathy. Last year, we encountered elderly individuals presenting with visual symptoms, headache, elevated sedimentation rates and C-reactive protein, all features characteristic of giant cell arteritis (GCA). GCA is a serious disease in which temporal artery biopsy reveals granulomatous vascular inflammation diagnostic of disease. However, the temporal arteries of our patients were negative for GCA pathology, but contained VZV antigen, indicative of multifocal VZV vasculopathy. Importantly, our earlier published studies revealed no VZV in temporal arteries from patients with pathologically verified GCA, indicating that the current cases of multifocal VZV vasculopathy with temporal artery infection are distinct from GCA. Since most patients with clinically-suspect GCA have a negative temporal artery biopsy, it is likely that a significant subset of these patients have multifocal VZV vasculopathy with temporal artery infection. In fact, our examination of GCA-negative temporal artery biopsies revealed VZV antigen in 5 (21%) of 24 arteries, providing the definitive rationale for our hypothesis that a significant proportion of patients with clinically-suspect GCA have multifocal VZV vasculopathy with temporal artery infection, an eminently treatable disorder. Our findings may also help to explain why temporal artery biopsy of patients with clinically-suspect GCA is negative in >50% of patients. We have archived temporal arteries from 150 subjects pathologically negative for GCA and will analyze an additional 1464 temporal arteries obtained from our collaborators at 7 major university hospitals in the next 5 years (total of 1614 arteries). We will determine the frequency of VZV in temporal arteries in GCA? negative subjects and identify the spectrum of clinical features, laboratory abnormalities and pathological changes in patients with VZV vasculopathy mimicking GCA. Proving that patients with clinical features and laboratory abnormalities suggestive of GCA are manifestations of multifocal VZV vasculopathy will significantly impact and change clinical practice. Patients presenting with symptoms of GCA may need treatment with both steroids and antiviral agents until a definitive diagnosis is made;otherwise, steroid treatment alone in patients with multifocal VZV vasculopathy may lead to blindness and stroke.

Public Health Relevance

Proving that patients with clinical features and laboratory abnormalities suggestive of giant cell arteritis (GCA) are manifestations of VZV vasculopathy will significantly impact and change clinical practice. Patients presenting with symptoms of GCA may need treatment with both steroids and antiviral agents until a definitive diagnosis is made;otherwise, steroid treatment alone in a patient with VZV vasculopathy may lead to blindness and stroke.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG032958-06
Application #
8636734
Study Section
Special Emphasis Panel (ZAG1-ZIJ-9 (02))
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
6
Fiscal Year
2014
Total Cost
$428,662
Indirect Cost
$150,863
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Yawn, Barbara P; Wollan, Peter C; Nagel, Maria A et al. (2016) Risk of Stroke and Myocardial Infarction After Herpes Zoster in Older Adults in a US Community Population. Mayo Clin Proc 91:33-44
Henderson, Heather H; Timberlake, Kensey B; Austin, Zoe A et al. (2016) Occupancy of RNA Polymerase II Phosphorylated on Serine 5 (RNAP S5P) and RNAP S2P on Varicella-Zoster Virus Genes 9, 51, and 66 Is Independent of Transcript Abundance and Polymerase Location within the Gene. J Virol 90:1231-43
Ouwendijk, Werner J D; Getu, Sarah; Mahalingam, Ravi et al. (2016) Characterization of the immune response in ganglia after primary simian varicella virus infection. J Neurovirol 22:376-88
Nagel, Maria A; Gilden, Don (2016) Developments in Varicella Zoster Virus Vasculopathy. Curr Neurol Neurosci Rep 16:12
Nagel, Maria A; Burns, Ted M; Gilden, Don (2016) SUNCT headaches after ipsilateral ophthalmic-distribution zoster. J Neurol Sci 366:207-8
Gilden, Don; White, Teresa; Khmeleva, Nelly et al. (2016) VZV in biopsy-positive and -negative giant cell arteritis: Analysis of 100+ temporal arteries. Neurol Neuroimmunol Neuroinflamm 3:e216
Jones, Dallas; Blackmon, Anna; Neff, C Preston et al. (2016) Varicella-Zoster Virus Downregulates Programmed Death Ligand 1 and Major Histocompatibility Complex Class I in Human Brain Vascular Adventitial Fibroblasts, Perineurial Cells, and Lung Fibroblasts. J Virol 90:10527-10534
Gilden, Don; Grose, Charles; White, Teresa et al. (2016) Successful antiviral treatment after 6years of chronic progressive neurological disease attributed to VZV brain infection. J Neurol Sci 368:240-2
Gilden, Don; Nagel, Maria A (2016) Varicella zoster virus triggers the immunopathology of giant cell arteritis. Curr Opin Rheumatol 28:376-82
Amlie-Lefond, Catherine; Gilden, Don (2016) Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults. J Stroke Cerebrovasc Dis 25:1561-9

Showing the most recent 10 out of 114 publications